Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection

Immunology

Volumn 129, Issue 4, 2010, Pages 556-566

  Jiang, Xiaozhou ^a   Shen, Caixia ^a   Yu, Hong ^a   Karunakaran, Karuna P ^a   Brunham, Robert C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adaptive immunity; Chlamydia muridarum; Innate immunity; Rodent; Susceptibility

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BAGG ALBINO MOUSE; BONE MARROW; C57BL 6 MOUSE; CELL MATURATION; CELLULAR IMMUNITY; CHLAMYDIA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; INOCULATION; LUNG INFECTION; LUNG PARENCHYMA; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HELA CELLS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; PNEUMONIA, BACTERIAL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77949391302     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03157.x     Document Type: Article

References (50)

1. Schachter J. Infection and disease epidemiology. In: Stephens RS, ed. Chlamydia. Intracellular Biology, Pathogenesis, and Immunity. Washington, DC: ASM Press, 1999:139-69.
2. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005; 5:149-61.
3. Zhang D, Yang X, Lu H, Zhong G, Brunham RC. Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation. Infect Immun 1999; 67:1606-13.
4. Eko FO, He Q, Brown T et al. A novel recombinant multisubunit vaccine against Chlamydia. J Immunol 2004; 173:3375-82.
5. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med 1998; 188:809-18.
6. Brunham RC, Zhang D. Transgene as vaccine for chlamydia. Am Heart J 1999; 138:S519-22.
7. Read TD, Brunham RC, Shen C et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000; 28:1397-406.
8. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002; 70:2741-51.
9. Darville T, Andrews CW Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997; 65:3065-73.
10. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996; 156:4338-44.
11. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995; 63:1784-9.
12. Shaw JH, Grund VR, Durling L, Caldwell HD. Expression of genes encoding Th1 cellactivating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy. Infect Immun 2001; 69:4667-72.
13. Su H, Caldwell HD. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 1995; 63:3302-8.
14. Perry LL, Feilzer K, Caldwell HD. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 1997; 158:3344-52.
15. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 1991; 59:925-31.
16. Lu H, Yang X, Takeda K et al. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity. Mol Med 2000; 6:604-12.
17. Huang J, Wang MD, Lenz S, Gao D, Kaltenboeck B. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue. J Immunol 1999; 162:2217-26.
18. Geng Y, Berencsi K, Gyulai Z, Valyi-Nagy T, Gonczol E, Trinchieri G. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun 2000; 68:2245-53.
19. Droemann D, Rupp J, Goldmann T et al. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:791-7.
20. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819-26.
21. Bai H, Yang J, Qiu H, Wang S, Fan Y, Han X, Xie S, Yang X. Intranasal inoculation of Chlamydia trachomatis mouse pneumonitis agent induces significant neutrophil infiltration which is not efficient in controlling the infection in mice. Immunology 2005; 114:246-54.
22. Jendro MC, Deutsch T, Korber B et al. Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection. Infect Immun 2000; 68:6704-11.
23. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998; 19:721-7.
24. Tseng CT, Rank RG. Role of NK cells in early host response to chlamydial genital infection. Infect Immun 1998; 66:5867-75.
25. Woolard MD, Hudig D, Tabor L, Ivey JA, Simecka JW. NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp. Infect Immun 2005; 73:6742-51.
26. Lu H, Xing Z, Brunham RC. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis. J Immunol 2002; 169:6324-31.
27. Yang X, Coriolan D, Schultz K, Golenbock DT, Beasley D. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2005; 25:2308-14.
28. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171:6187-97.
29. O'Connell CM, Ingalls RR, Andrews CW Jr, Scurlock AM, Darville T. Plasmid-defi-cient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 2007; 179:4027-34.
30. Qiu H, Wang S, Yang J, Fan Y, Joyee AG, Han X, Jiao L, Yang X. Resistance to chlamydial lung infection is dependent on major histocompatibility complex as well as non-major histocompatibility complex determinants. Immunology 2005; 116:499-506.
31. Jupelli M, Guentzel MN, Meier PA, Zhong G, Murthy AK, Arulanandam BP. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. J Immunol 2008; 180:4148-55.
32. Miyairi I, Tatireddigari VR, Mahdi OS, Rose LA, Belland RJ, Lu L, Williams RW, Byrne GI. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J Immunol 2007; 179:1814-24.
33. Skwor TA, Atik B, Kandel RP, Adhikari HK, Sharma B, Dean D. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease. PLoS Negl Trop Dis 2008; 2: e264, 1-12.
34. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31:1161-76.
35. Zaharik ML, Nayar T, White R et al. Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles. Immunology 2007; 120:160-72.
36. Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun 2008; 76:2392-401.
37. Huppert M, Sun SH, Gleason-Jordon I, Vukovich KR. Lung weight parallels disease severity in experimental coccidioidomycosis. Infect Immun 1976; 14:1356-68.
38. Natividad A, Hanchard N, Holland MJ et al. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun 2007; 8:288-95.
39. Holtmann H, Shemer-Avni Y, Wessel K, Sarov I, Wallach D. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect Immun 1990; 58:3168-72.
40. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, Jennings R, Mbena E, Mabey DC. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 1997; 65:1003-6.
41. Darville T, Andrews CW Jr, Rank RG. Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs? Infect Immun 2000; 68:5299-305.
42. Williams DM, Grubbs BG, Darville T, Kelly K, Rank RG. A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect Immun 1998; 66:4564-7.
43. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-52.
44. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-7.
45. Shaw J, Grund V, Durling L, Crane D, Caldwell HD. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun 2002; 70:1097-105.
46. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH, Probst P. Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun 2004; 72:7231-9.
47. Williams NL, Kloeze E, Govan BL, Körner H, Ketheesan N. Burkholderia pseudomallei enhances maturation of bone marrow-derived dendritic cells. Trans R Soc Trop Med Hyg 2008; 102:S71-5.
48. Pejawar SS, Parks GD, Alexander-Miller MA. Abortive versus productive viral infection of dendritic cells with a paramyxovirus results in differential upregulation of select costimulatory molecules. J Virol 2005; 79:7544-57.
49. Harada T, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. Highly expressed dectin-1 on bone marrow-derived dendritic cells regulates the sensitivity to beta-glucan in DBA/2 mice. J Interferon Cytokine Res 2008; 28:477-86.
50. Koike E, Takano H, Inoue K, Yanagisawa R. Accelerated differentiation of bone marrow-derived dendritic cells in atopic prone mice. Int Immunopharmacol 2008; 8:1737-43.